BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38743830)

  • 21. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
    Gebauer F; Tachezy M; Vashist YK; Marx AH; Yekebas E; Izbicki JR; Bockhorn M
    World J Surg; 2015 Feb; 39(2):493-9. PubMed ID: 25270344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.
    Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A
    BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival.
    Fatima J; Schnelldorfer T; Barton J; Wood CM; Wiste HJ; Smyrk TC; Zhang L; Sarr MG; Nagorney DM; Farnell MB
    Arch Surg; 2010 Feb; 145(2):167-72. PubMed ID: 20157085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival.
    Tjaden C; Hinz U; Klaiber U; Heger U; Springfeld C; Goeppert B; Schmidt T; Mehrabi A; Strobel O; Berchtold C; Schneider M; Diener M; Neoptolemos JP; Hackert T; Büchler MW
    Ann Surg; 2023 Jan; 277(1):e112-e118. PubMed ID: 34171863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued.
    Mathur A; Ross SB; Luberice K; Kurian T; Vice M; Toomey P; Rosemurgy AS
    Am Surg; 2014 Apr; 80(4):353-60. PubMed ID: 24887665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
    Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
    Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Klaiber U; Schnaidt ES; Hinz U; Gaida MM; Heger U; Hank T; Strobel O; Neoptolemos JP; Mihaljevic AL; Büchler MW; Hackert T
    Ann Surg; 2021 Jan; 273(1):154-162. PubMed ID: 30921051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma.
    Schneider C; Sodergren MH; Pencavel T; Soggiu F; Bhogal RH; Khan AZ
    Surg Oncol; 2020 Dec; 35():211-217. PubMed ID: 32911213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
    Sahakyan MA; Verbeke CS; Tholfsen T; Ignjatovic D; Kleive D; Buanes T; Lassen K; Røsok BI; Labori KJ; Edwin B
    Ann Surg Oncol; 2022 Jan; 29(1):366-375. PubMed ID: 34296358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological assessment of prognostic factors in pancreatic resection specimens using a standardised protocol.
    Silvanto A; Balamurugan T; Bagwan IN
    Pathologica; 2019 Mar; 111(1):24-30. PubMed ID: 31217619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
    Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
    Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-Operative Frozen Section Histology of the Pancreatic Resection Margins and Clinical Outcome of Patients with Adenocarcinoma of the Head of the Pancreas Undergoing Pancreaticoduodenectomy.
    Dikmen K; Kerem M; Bostanci H; Sare M; Ekinci O
    Med Sci Monit; 2018 Jul; 24():4905-4913. PubMed ID: 30007990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does revision of resection margins based on frozen section improve overall survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma? A meta-analysis.
    Barreto SG; Pandanaboyana S; Ironside N; Windsor JA
    HPB (Oxford); 2017 Jul; 19(7):573-579. PubMed ID: 28420560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.